ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,917.11
0.00%
US Tech 100
20,029.20
-0.54%
Dow Jones
43,408.47
0.32%
Brent Oil
72.785
-0.08%
Bitcoin
97,367.56
3.20%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Pyxis Oncology Inc (PYXS) Quote

Pyxis Oncology Inc

Pyxis Oncology Inc (PYXS)

NASDAQ
3.82
-0.34
(-8.17%)
Closed November 21 4:00PM
Delayed by 15 minutes
2.26
-1.56
(-40.84%)
After Hours: 7:59PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
2.26
Bid
2.25
Ask
2.26
Volume
5,457,154
3.80 Day's Range 4.31
1.35 52 Week Range 6.85
Market Cap
134.393M
Previous Close
4.16
Open
4.25
Last Trade
100
@
2.26
(formt)
Last Trade Time
Financial Volume
$ 21,842,394
VWAP
4.0025
Average Volume (3m)
557,504
Shares Outstanding
59,465,729
Dividend Yield
-
PE Ratio
-3.09
Earnings Per Share (EPS)
-1.24
Revenue
-
Net Profit
-73.79M

About Pyxis Oncology Inc

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the ... Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
pyxisoncology.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Pyxis Oncology Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PYXS. The last closing price for Pyxis Oncology was $4.16. Over the last year, Pyxis Oncology shares have traded in a share price range of $ 1.35 to $ 6.85.

Pyxis Oncology currently has 59,465,729 shares outstanding. The market capitalization of Pyxis Oncology is $247.38 million. Pyxis Oncology has a price to earnings ratio (PE ratio) of -3.09.

Ask ADVFN Intelligence (AI)

PYXS Latest News

More News

Form 8-K - Current report

9 hours ago
Edgar (US Regulatory)

Pyxis Oncology Announces Favorable Preliminary PYX-201 Clinical Phase 1 Part 1 Data

— PYX-201 achieved a confirmed 50% ORR by RECIST 1.1 including one Complete Response and 100% Disease Control Rate in six heavily pretreated HNSCC patients, supporting differentiated mono and...

9 hours ago
GlobeNewswire Inc.

Form S-8 - Securities to be offered to employees in employee benefit plans

November 12 2024
Edgar (US Regulatory)

Pyxis Oncology Provides Corporate Update and Reports Financial Results for Third Quarter 2024

- Preliminary data from the first-in-patient Phase 1 dose escalation trial of PYX-201 to be announced at upcoming virtual and in-person event in New York City on Wednesday, November 20, 2024, at...

November 12 2024
GlobeNewswire Inc.

Pyxis Oncology to Host In-Person (NYC) and Virtual Investor Event on Wednesday, November 20, 2024, to Present Preliminary Data from the Phase 1 Dose Escalation Trial of PYX-201

BOSTON, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers...

November 11 2024
GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

November 06 2024
Edgar (US Regulatory)

Form 8-K - Current report

October 23 2024
Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements

September 25 2024
Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements

September 13 2024
Edgar (US Regulatory)

Pyxis Oncology to Participate in Two Upcoming Investor Conferences

BOSTON, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers...

August 29 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-2.49-52.42105263164.755.51.927573794.21886701CS
4-1.23-35.24355300863.495.51.926173044.13814843CS
12-1.4-38.25136612023.665.51.925575043.78801334CS
26-1.85-45.01216545014.115.51.925132473.62608967CS
520.8459.15492957751.426.851.355561404.07363843CS
156-10.34-82.063492063512.613.31.15967793.98208724CS
260-16.74-88.105263157919191.15855564.16255027CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
FBRXForte Biosciences Inc
$ 13.60
(129.53%)
28.92M
QSIQuantum Si Inc
$ 1.39
(119.59%)
279.33M
XCURExicure Inc
$ 11.01
(89.18%)
22.91M
AGFYAgrify Corporation
$ 37.4635
(68.00%)
921.45k
SLXNSilexion Therapeutics Corporation
$ 0.3495
(54.51%)
198.66M
SKKSKK Holdings Limited
$ 4.55
(-47.28%)
816.93k
QMMMQMMM Holdings Limited
$ 0.713999
(-43.78%)
4.61M
XTKGX3 Holdings Company Ltd
$ 0.0901
(-37.82%)
5.95M
PRFXPainReform Ltd
$ 1.02
(-27.14%)
5.09M
GLEGlobal Engine Group Holding Ltd
$ 3.81
(-26.59%)
230.23k
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.191
(17.39%)
662.68M
DBGIDigital Brands Group Inc
$ 0.1345
(15.35%)
326.45M
NVDANVIDIA Corporation
$ 145.89
(-0.76%)
309.57M
QSIQuantum Si Inc
$ 1.39
(119.59%)
283.09M
SLXNSilexion Therapeutics Corporation
$ 0.3495
(54.51%)
200.06M

PYXS Discussion

View Posts
Monksdream Monksdream 8 months ago
PYXS under $5
👍️0
Awl416 Awl416 9 months ago
Pyxis Oncology Announces $50 Million Private Placement
👍️0
euroconversions euroconversions 1 year ago
Insiders buying, always a good sign.
PYXS Long
👍️0
jack7377 jack7377 2 years ago
PYSX#$$: Hey Bulba and JuneBugs , this Log Legged Loin Puppy is getting ready to Break it's Chain,Leap and go on an Epic Run North. Friday's 1st Qtr Financials are going to make this spring 200-300%.
👍️0
TheFinalCD TheFinalCD 2 years ago
I did, nice P&D

https://www.tiktok.com/@stockdads/video/7217125391520091434
👍️0
SpaceTimeRift777 SpaceTimeRift777 2 years ago
Wouldn't touch it until we see if that $3 support can hold
GL
👍️0
spencer22 spencer22 2 years ago
Perfect example of dilution,in other words a classic pump and dump in my opinion!
👍️ 1
0210 0210 2 years ago
7). $10.75 PYXS Target Price @ Fin Viz.

8). BUY Rating $14.00 PYXS PT @ Market Beat.

9). $10.75 PT +++Positive+++ Short, Medium and Long Term Performance Outlook, Yahoo Finance.

10). BUY Rating @Reuters.
👍️0
0210 0210 2 years ago
buyin' dips $4.00 - $4.10. 14m BUYs (+5m?) vs. 12m Sells this Friday. hmmm.....

1). 88% Buy, up from 72% buy last week and 40% Buy, a month ago @Barchart.

2). Stay Long @ American Bulls.

3). $10.75 Price Target, from 5 analysts @Barrons.

4). $4.00 >$11.50 > $16.00 Price Targets @CNN Business.

5). HOLD Rating @ Zacks.

6). $11.22 TP mean rating, Chartmill.
👍️0
interloper interloper 2 years ago
I just heard the same thing from a cousin who said it was on Reddit.
👍️0
Jess070283 Jess070283 2 years ago
That dip was a gift. Loaded way oversold.
👍️0
magacrew2020 magacrew2020 2 years ago
potential halt at $2. seems to be fair value
👍️0
da_stock_analyst da_stock_analyst 2 years ago
#PYXS ?? big squeeze coming??!! Attractive bullish chart! $PYXS
👍️0
Pyramid2 Pyramid2 2 years ago
* * > $7 halt < * *

Went short $6.85 and they halted it $6.92 and she dropped. I thought not again just like SVIBQ and it will open 2 weeks later at $100. I am still waiting to get my trading groove back. This thing has been a rocket from $3.92 yesterday. No position now closed out on $6 close.

glta.
👍️0
SpaceTimeRift777 SpaceTimeRift777 2 years ago
Better lock profits today this will come back down to earth

Way Overbought
👍️0
SpaceTimeRift777 SpaceTimeRift777 2 years ago
One hell of a Moon Market pump
👍️0
jakec21 jakec21 2 years ago
Please post something that you have proof. You r on my radar alert
👍️0
TrendTrade2016 TrendTrade2016 2 years ago
PYXS....MONSTER TAKING OFF!!
👍️0
PickItToWin PickItToWin 2 years ago
Thorough DD is how I found my info and jumped in at $2. Definitely happy with my ROI this week, hope others took advantaged as well. GLTA
👍️0
eastunder eastunder 2 years ago
It's from a tiktok video...

Where all valid information comes from.
👍️0
da_stock_analyst da_stock_analyst 2 years ago
#PYXS ?? can it double from here? very bullish chart! see the video $PYXS
👍️0
TheFinalCD TheFinalCD 2 years ago
hmmmm, any info or articles to back your post up?


Message in reply to:
Target price is $12-$16. Nancy Pelosi’s husband just scooped up a bunch of PYXS and he somehow always has the inside scoop on stocks ;)
👍️0
Jess070283 Jess070283 2 years ago
Beast!$$$
👍️0
Randyfloyd420 Randyfloyd420 2 years ago
Yea what a joke
👍️0
eastunder eastunder 2 years ago
I did. There is nothing that I found that backed that up.

So if you have something, cam you please post a link?

I really am curious.

I don't see Pelosi buying something like this.

Why?
👍️0
PickItToWin PickItToWin 2 years ago
Just do a Google search on Pyxs and Nancy Pelosi. She’s not the only one buying it up.
👍️0
eastunder eastunder 2 years ago
How do you know that?
👍️0
PickItToWin PickItToWin 2 years ago
Target price is $12-$16. Nancy Pelosi’s husband just scooped up a bunch of PYXS and he somehow always has the inside scoop on stocks ;)
👍️0
Amatuer17 Amatuer17 2 years ago
Seems an interesting play in ADC
👍️0

Your Recent History

NASDAQ
PYXS
Pyxis Oncology
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved